SEC Form 13F
| Report period | 2026-06-30 |
|---|---|
| Publicly available | 2026-08-14 |
| Reported value | $586,539,478 |
| Positions | 15 |
| Issuer | Ticker | Class | Reported value | Reported amount |
|---|---|---|---|---|
| BIONTECH SE | BNTX | SPONSORED ADS | $70,210,878 | 754,550 |
| ROIVANT SCIENCES LTD | ROIV | SHS | $68,405,473 | 1,932,904 |
| ROYALTY PHARMA PLC | RPRX | SHS CLASS A | $64,806,211 | 1,155,809 |
| IONIS PHARMACEUTICALS INC | IONS | COM | $63,329,637 | 798,709 |
| INSMED INC | INSM | COM PAR $.01 | $59,688,435 | 559,824 |
| REGENERON PHARMACEUTICALS | REGN | COM | $57,764,746 | 92,640 |
| LEGEND BIOTECH CORP | LEGN | SPONSORED ADS | $34,411,155 | 1,191,522 |
| ALNYLAM PHARMACEUTICALS INC | ALNY | COM | $34,041,978 | 113,085 |
| NATERA INC | NTRA | COM | $32,295,764 | 118,975 |
| STRUCTURE THERAPEUTICS INC | GPCR | SPONSORED ADS | $23,939,987 | 446,059 |
Public filing evidence only. NexusTrade's simulated follower strategies are hypothetical, modeled results — not live trading returns and not investment advice.